Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05158777
What this trial is testing

Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old

Who this might be right for
Varicella
Shanghai Institute Of Biological Products 2,480
Testing effectiveness (Phase 2)UnknownNCT05273528
What this trial is testing

The Immunogenicity and Safety of V-01-351/V-01D Bivalence Vaccine

Who this might be right for
COVID-19 Pandemic
Livzon Pharmaceutical Group Inc. 20
Early research (Phase 1)Study completedNCT01800071
What this trial is testing

A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CancerEpstein Barr Virus Infections
Cancer Research UK 22
Large-scale testing (Phase 3)Study completedNCT00944034
What this trial is testing

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 1,588
Large-scale testing (Phase 3)Study completedNCT01884519
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older

Who this might be right for
Influenza
GlaxoSmithKline 120
Not applicableStudy completedNCT03541694
What this trial is testing

Passive Enhanced Safety Surveillance of Stamaril® Vaccine in Korea

Who this might be right for
Yellow Fever
Sanofi Pasteur, a Sanofi Company 622
Testing effectiveness (Phase 2)Ended earlyNCT00508651
What this trial is testing

A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of Age

Who this might be right for
Healthy
MedImmune LLC 30
Large-scale testing (Phase 3)Study completedNCT03480802
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 302
Large-scale testing (Phase 3)Study completedNCT00505453
What this trial is testing

A Phase III, Open-Label, Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral® Vaccine

Who this might be right for
Influenza
GlaxoSmithKline 110
Early research (Phase 1)Looking for participantsNCT06878612
What this trial is testing

A Polyphenol Whole Tumor Cell Vaccine in Patients With Advanced Malignant Solid Tumors

Who this might be right for
PolyphenolsCancer VaccineAdvanced Solid Tumor
Xingchen Peng 9
Post-approval studies (Phase 4)UnknownNCT05085145
What this trial is testing

Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV

Who this might be right for
People Living With HIVCOVID-19Vaccine
Beijing 302 Hospital 200
Large-scale testing (Phase 3)Study completedNCT00427895
What this trial is testing

Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults

Who this might be right for
Pneumococcal Infections
Pfizer 2,141
Testing effectiveness (Phase 2)WithdrawnNCT01045564
What this trial is testing

Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

Who this might be right for
Influenza
GlaxoSmithKline
Not applicableStudy completedNCT01396434
What this trial is testing

Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos

Who this might be right for
Pneumococcal Disease
Pfizer 3,006
Large-scale testing (Phase 3)Study completedNCT02993757
What this trial is testing

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Papillomavirus Disease
Sanofi Pasteur, a Sanofi Company 528
Testing effectiveness (Phase 2)Study completedNCT01701999
What this trial is testing

Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid

Who this might be right for
Botulism
California Department of Public Health 45
Testing effectiveness (Phase 2)Study completedNCT00915187
What this trial is testing

Safety and Immunogenicity Study of Intramuscular CCS/C-adjuvanted Influenza Vaccine in Elderly

Who this might be right for
Influenza
NasVax Ltd 130
Early research (Phase 1)UnknownNCT05354063
What this trial is testing

SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Older Adults.

Who this might be right for
SARS-CoV-2
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT04544787
What this trial is testing

Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates

Who this might be right for
Poliomyelitis
Pierre Van Damme 250
Not applicableStudy completedNCT00711321
What this trial is testing

Long-term Safety and Tolerability of AFFITOPE AD02

Who this might be right for
Alzheimer's Disease
Affiris AG 23
Next Page